Agenus IncAGEN

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$8.54
Market cap
$384.5M
P/E
4.2x
Revenue (TTM)
$132.7M
Net income
$92.0M
Dividend yield
—
1-year total return
119.0%
Net margin
69.3%
Revenue growth
30.5%
Debt / equity
—

What Agenus Inc does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$88.2M$295.7M$98.0M$156.3M$103.5M$114.2M
Net income-$180.9M-$23.9M-$220.1M-$245.8M-$227.2M$115,000
Free cash flow-$142.6M-$23.7M-$228.4M-$234.2M-$158.9M-$77.2M

More on AGEN.

Figures from Agenus Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.